Complement component 4 genes contribute sex-specific vulnerability in diverse illnesses

Many common illnesses differentially affect men and women for unknown reasons. The autoimmune diseases lupus and Sjögren’s syndrome affect nine times more women than men1,2, whereas schizophrenia affects men more frequently and severely3–5. All three illnesses have their strongest common-genetic associations in the Major Histocompatibility Complex (MHC) locus, an association that in lupus and Sjögren’s syndrome has long been thought to arise from HLA alleles6–13. Here we show that the complement component 4 (C4) genes in the MHC locus, recently found to increase risk for schizophrenia14, generate 7-fold variation in risk for lupus (95% CI: 5.88-8.61; p < 10−117 in total) and 16-fold variation in risk for Sjögren’s syndrome (95% CI: 8.59-30.89; p < 10−23 in total), with C4A protecting more strongly than C4B in both illnesses. The same alleles that increase risk for schizophrenia, greatly reduced risk for lupus and Sjögren’s syndrome. In all three illnesses, C4 alleles acted more strongly in men than in women: common combinations of C4A and C4B generated 14-fold variation in risk for lupus and 31-fold variation in risk for Sjögren’s syndrome in men (vs. 6-fold and 15-fold among women respectively) and affected schizophrenia risk about twice as strongly in men as in women. At a protein level, both C4 and its effector (C3) were present at greater levels in men than women in cerebrospinal fluid (p < 10−5 for both C4 and C3) and plasma among adults ages 20-5015–17, corresponding to the ages of differential disease vulnerability. Sex differences in complement protein levels may help explain the larger effects of C4 alleles in men, women’s greater risk of SLE and Sjögren’s, and men’s greater vulnerability in schizophrenia. These results nominate the complement system as a source of sexual dimorphism in vulnerability to diverse illnesses.

[1]  L. Trouw,et al.  Age and Sex-Associated Changes of Complement Activity and Complement Levels in a Healthy Caucasian Population , 2018, Front. Immunol..

[2]  P. Gaffney,et al.  Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans , 2018, Human molecular genetics.

[3]  Vitor R. C. Aguiar,et al.  Expression estimation and eQTL mapping for HLA genes with a personalized pipeline , 2018, bioRxiv.

[4]  W. Lieb,et al.  Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus , 2017, Lupus.

[5]  Nicola J. Rinaldi,et al.  Genetic effects on gene expression across human tissues , 2017, Nature.

[6]  Dong Sook Kim,et al.  Incidence, mortality, and causes of death in physician-diagnosed primary Sjögren's syndrome in Korea: A nationwide, population-based study. , 2017, Seminars in arthritis and rheumatism.

[7]  S. Degn,et al.  Clonal Evolution of Autoreactive Germinal Centers , 2017, Cell.

[8]  P. Gregersen,et al.  Transancestral mapping and genetic load in systemic lupus erythematosus , 2017, Nature Communications.

[9]  Stephan J Sanders,et al.  Whole genome sequencing in psychiatric disorders: the WGSPD consortium , 2017, bioRxiv.

[10]  Caitlin P. McHugh,et al.  Genome‐Wide Association Analysis Reveals Genetic Heterogeneity of Sjögren's Syndrome According to Ancestry , 2017, Arthritis & rheumatology.

[11]  E. Matteson,et al.  Incidence and Mortality of Physician‐Diagnosed Primary Sjögren Syndrome: Time Trends Over a 40‐Year Period in a Population‐Based US Cohort , 2017, Mayo Clinic proceedings.

[12]  R. Fischer-Betz,et al.  Age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002 , 2016, Lupus Science & Medicine.

[13]  A. Vita,et al.  Schizophrenia , 2016, The Lancet.

[14]  R. H. Scofield,et al.  Autoantibodies in Sjögren's Syndrome. , 2016, Rheumatic diseases clinics of North America.

[15]  H. Nagaraja,et al.  Effects of Complement C4 Gene Copy Number Variations, Size Dichotomy, and C4A Deficiency on Genetic Risk and Clinical Presentation of Systemic Lupus Erythematosus in East Asian Populations , 2016, Arthritis & rheumatology.

[16]  P. Gaffney,et al.  Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity , 2016, eLife.

[17]  Giulio Genovese,et al.  Schizophrenia risk from complex variation of complement component 4 , 2016, Nature.

[18]  Brian L Browning,et al.  Genotype Imputation with Millions of Reference Samples. , 2016, American journal of human genetics.

[19]  A. Valdes,et al.  Familial Risk of Sjögren's Syndrome and Co‐aggregation of Autoimmune Diseases in Affected Families: A Nationwide Population Study , 2015, Arthritis & rheumatology.

[20]  Swneke D. Bailey,et al.  ZNF143 provides sequence specificity to secure chromatin interactions at gene promoters , 2015, Nature Communications.

[21]  R. Handsaker,et al.  Large multi-allelic copy number variations in humans , 2015, Nature Genetics.

[22]  R. Ophoff,et al.  Vitamin B-6 vitamers in human plasma and cerebrospinal fluid. , 2014, The American journal of clinical nutrition.

[23]  P. Mccombe,et al.  Gender differences in autoimmune disease , 2014, Frontiers in Neuroendocrinology.

[24]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[25]  P. Gregersen,et al.  MHC associations with clinical and autoantibody manifestations in European SLE , 2014, Genes and Immunity.

[26]  P. Gaffney,et al.  Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren’s syndrome , 2013, Nature Genetics.

[27]  S. Mccarroll,et al.  The genomic psychiatry cohort: Partners in discovery , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[28]  B S Weir,et al.  HIBAG—HLA genotype imputation with attribute bagging , 2013, The Pharmacogenomics Journal.

[29]  L. Suresh,et al.  Novel autoantibodies in Sjogren's syndrome. , 2012, Clinical immunology.

[30]  P. Gregersen,et al.  Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans. , 2012, American journal of human genetics.

[31]  Á. Szilágyi,et al.  Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes , 2012, Genes and Immunity.

[32]  Raymond K. Auerbach,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[33]  L. Criswell,et al.  Primary Sjögren's syndrome as a systemic disease: A study of participants enrolled in an International Sjögren's syndrome registry , 2012, Arthritis care & research.

[34]  R. Ophoff,et al.  A Common Variant in ERBB4 Regulates GABA Concentrations in Human Cerebrospinal Fluid , 2012, Neuropsychopharmacology.

[35]  Jayashri Kulkarni,et al.  Gender Differences in Schizophrenia and First-Episode Psychosis: A Comprehensive Literature Review , 2012, Schizophrenia research and treatment.

[36]  D. Morris,et al.  Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations. , 2012, American journal of human genetics.

[37]  J. Anaya,et al.  HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies. , 2012, Autoimmunity reviews.

[38]  Robert M. Plenge,et al.  Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis , 2011, Nature Genetics.

[39]  P. Gaffney,et al.  Analysis of autosomal genes reveals gene–sex interactions and higher total genetic risk in men with systemic lupus erythematosus , 2011, Annals of the rheumatic diseases.

[40]  C. Wijbrandts,et al.  Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared to 2010 ACR/EULAR criteria): a prospective study aimed at identification of diagnostic and prognostic biomarkers as well as therapeutic targets , 2011, Annals of the rheumatic diseases.

[41]  M. Boaz,et al.  Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. , 2011, Seminars in arthritis and rheumatism.

[42]  Annette Lee,et al.  Differential Genetic Associations for Systemic Lupus Erythematosus Based on Anti–dsDNA Autoantibody Production , 2011, PLoS genetics.

[43]  D. Gladman,et al.  Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity , 2011, Lupus.

[44]  T. Niewold,et al.  The Unexplained Female Predominance of Systemic Lupus Erythematosus: Clues from Genetic and Cytokine Studies , 2011, Clinical reviews in allergy & immunology.

[45]  J. Goldstein,et al.  Sex differences in schizophrenia , 2010, International review of psychiatry.

[46]  F. Irshaid,et al.  The complex nature of serum C3 and C4 as biomarkers of lupus renal flare , 2010, Lupus.

[47]  Stephen L. Hauser,et al.  Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases , 2009, Proceedings of the National Academy of Sciences.

[48]  C. Y. Yu,et al.  Molecular basis of complete complement C4 deficiency in two North-African families with systemic lupus erythematosus , 2009, Genes and Immunity.

[49]  B. Chadwick,et al.  The insulator factor CTCF controls MHC class II gene expression and is required for the formation of long-distance chromatin interactions , 2008, The Journal of experimental medicine.

[50]  Marta E Alarcón-Riquelme,et al.  Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci , 2008, Nature Genetics.

[51]  B. Browning,et al.  Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. , 2007, American journal of human genetics.

[52]  Bi Zhou,et al.  Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. , 2007, American journal of human genetics.

[53]  P. Majumder,et al.  The Human Major Histocompatibility Complex Class II HLA-DRB1 and HLA-DQA1 Genes Are Separated by a CTCF-binding Enhancer-blocking Element* , 2006, Journal of Biological Chemistry.

[54]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[55]  P. Lipsky Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity , 2001, Nature Immunology.

[56]  Don C. Wiley,et al.  Structure of a human insulin peptide–HLA-DQ8 complex and susceptibility to type 1 diabetes , 2001, Nature Immunology.

[57]  A. Riecher-Rössler,et al.  The Epidemiology of Early Schizophrenia , 1994, British Journal of Psychiatry.

[58]  E. Thorsby,et al.  Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients , 1993, The Journal of experimental medicine.

[59]  Lawrence Js,et al.  A family survey of lupus erythematosus. 1. Heritability. , 1987 .

[60]  R. Porter,et al.  Structure and organization of the C4 genes. , 1984, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[61]  P. Densen,et al.  Complement Deficiency States and Infection: Epidemiology, Pathogenesis and Consequences of Neisserial and Other Infections in an Immune Deficiency , 1984, Medicine.

[62]  R. Porter,et al.  A comparison of the properties of two classes, C4A and C4B, of the human complement component C4. , 1984, The EMBO journal.

[63]  J. Young,et al.  The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4. , 1984, Journal of immunology.

[64]  D. Bentley,et al.  A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B , 1984, Nature.

[65]  P. Terasaki,et al.  Sjögren's Syndrome Associated with HLA-Dw3 , 1977 .

[66]  D. Isenberg,et al.  How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project). , 2018, Clinical and experimental rheumatology.

[67]  Xiuwen Zheng,et al.  Imputation-Based HLA Typing with SNPs in GWAS Studies. , 2018, Methods in molecular biology.

[68]  Annette Lee,et al.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. , 2008, The New England journal of medicine.

[69]  J. Yagüe,et al.  Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome. , 2005, Rheumatology.

[70]  G. Palomaki,et al.  Reference distributions for complement proteins C3 and C4: A comparison of a large cohort to the world's literature , 2004, Journal of clinical laboratory analysis.

[71]  G. Palomaki,et al.  Reference distributions for complement proteins C3 and C4: A practical, simple and clinically relevant approach in a large cohort , 2004, Journal of clinical laboratory analysis.

[72]  K. H. Lee Structure of a human insulin peptide–HLA-DQ8 complex and susceptibility to type 1 diabetes , 2001, Nature Immunology.

[73]  C. Martins,et al.  A family survey of lupus erythematosus. 1. Heritability. , 1987, The Journal of rheumatology.